Early stage human trial data shows Oxford COVID-19 vaccine provides antibodies and killer T cells

The COVID-19 vaccine being developed by researchers at the University of Oxford is considered one of the leading in the world, and researchers announced promising results of its first human trials. Charlie D'Agata reports on the vaccine that could provide a one-two punch against COVID-19.